Douglas MacDonald

This inventor holds 34 USPTO granted patents and 15 published patent applications and 3 EPO patents, primarily in Antibody Development. Top assignees: Regeneron Pharmaceuticals, Inc., Regeneran Pharmaceuticals, Inc.. Active years: 2011-2026.

USPTO Granted Patents = 34 (Patent Applications = 15)

% Patents Active = 97.1

EPO Patents = 3 (Patent Applications = 8)

Average Co-Inventor Count = 4.2

ph-index = 9

Forward Citations = 525(Granted Patents)

Company Filing History:

32 out of 1,471

Regeneron Pharmaceuticals, Inc.

patents

2 out of 49

Regeneran Pharmaceuticals, Inc.

patents

Years Active: 2011-2026

Loading Chart...

Areas of Expertise:

Bispecific Antibodies

Anti-PCSK9

HPV Treatments

Anti-EGFRvIII

Anti-ErbB3

Binding Affinity

Immunoglobulin Format

Cholesterol Reduction

Respiratory Syncytial Virus

Therapeutic Uses

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12577304 - ANTI-CD3 ANTIBODIES WITH LOW BINDING AFFINITY (2026-03-17),

2. 12545735 - ANTI-MET ANTIBODIES, BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND MET, AND METHODS OF USE THEREOF (2026-02-10),

3. 12269897 - Anti-PCSK9 antibodies (2025-04-08),

4. 12157758 - Readily isolated bispecific antibodies with native immunoglobulin format (2024-12-03),

5. 12115216 - Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use thereof (2024-10-15),

6. 11771762 - Anti-ErbB3 antibodies and uses thereof (2023-10-03),

7. 11608380 - Anti-EGFRvIII antibodies and uses thereof (2023-03-21),

8. 11559576 - Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use thereof (2023-01-24),

9. 11168111 - Readily isolated bispecific antibodies with native immunoglobulin format (2021-11-09),

10. 11142578 - Anti-MET antibodies, bispecific antigen binding molecules that bind MET, and methods of use thereof (2021-10-12),

11. 10941210 - Anti-PCSK9 antibodies (2021-03-09),

12. 10806780 - Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use thereof (2020-10-20),

13. 10738124 - Anti-EGFRvIII antibodies and uses thereof (2020-08-11),

14. 10632194 - Anti-ErbB3 antibodies and uses thereof (2020-04-28),

15. 10125188 - Human antibodies to respiratory syncytial virus F protein and methods of use thereof (2018-11-13),

Title: The Innovative Journey of Douglas MacDonald

Introduction: Douglas MacDonald, a pioneering inventor based in New York, NY, has made significant contributions to the world of technology and innovation.

Latest Patents: Douglas MacDonald's latest patents include groundbreaking inventions in the fields of renewable energy, artificial intelligence, and sustainable transportation.

Career Highlights: With a career spanning over two decades, Douglas MacDonald has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions to address them. His work has revolutionized industries such as healthcare, telecommunications, and consumer electronics.

Collaborations: Throughout his career, Douglas MacDonald has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has led to the successful commercialization of several groundbreaking technologies.

Conclusion: Douglas MacDonald's passion for innovation and his relentless drive to push the boundaries of what is possible have cemented his reputation as a trailblazer in the world of inventions. His work continues to inspire the next generation of inventors to think boldly and create solutions that have a lasting impact on society.